Phase II Trial of Fulvestrant and Bevacizumab in Patients With Metastatic Breast Cancer Previously Treated With an Aromatase Inhibitor.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 06 Apr 2017
At a glance
- Drugs Fulvestrant (Primary) ; Bevacizumab
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 10 Jul 2015 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov.
- 18 Jun 2012 Actual end date (Feb 2009) added as reported by ClinicalTrials.gov.
- 18 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.